Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 19, Issue 1, pp. 101-111
PubMed
Published By
Print ISSN
Online ISSN
History
- Received April 10, 2019
- Revision received July 24, 2019
- Accepted September 12, 2019
- Published first September 17, 2019.
Article Versions
- Previous version (September 17, 2019 - 07:44).
- Previous version (December 12, 2019 - 07:11).
- You are viewing the most recent version of this article.
Copyright & Usage
©2019 American Association for Cancer Research.
Author Information
- Chia-Ling Hsieh1,2,
- Hsu-Shan Huang3,
- Kuan-Chou Chen4,5,6,
- Teigi Saka4,
- Chih-Ying Chiang1,
- Leland W.K. Chung7, and
- Shian-Ying Sung1,2,8,9,*
- 1The Ph.D. Program for Translational Medicine, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.
- 2TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei, Taiwan.
- 3Graduate Institute of Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.
- 4Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
- 5Department of Urology, College of Medicine, Taipei Medical University, Taipei, Taiwan.
- 6Department of Urology, Taipei Medical University-Shuang Ho Hospital, New Taipei City, Taiwan.
- 7Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California.
- 8Joint Clinical Research Center, Office of Human Research, Taipei Medical University, Taipei, Taiwan.
- 9Clinical Research Center, Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan.
- ↵*Corresponding Author:
Shian-Ying Sung, The Ph.D. Program for Translational Medicine, College of Medical Science and Technology, Taipei Medical University, 250 Wu-Hsing Street, Taipei 11031, Taiwan. Phone: 88-62269-72035, ext. 105; E-mail: ssung{at}tmu.edu.tw
January 2020
Volume 19, Issue 1
Volume 19, Issue 1
A Novel Salicylanilide Derivative Induces Autophagy Cell Death in Castration-Resistant Prostate Cancer via ER Stress-Activated PERK Signaling Pathway
Jump to section
Advertisement